Generated by AI
Valneva SE Sponsored ADR is an American depositary receipt representing shares of Valneva SE, a specialty vaccine company focused on the development, manufacture, and commercialization of prophylactic vaccines for infectious diseases with unmet medical needs. Valneva’s current portfolio includes vaccines for travel and endemic disease prevention, serving public health, travel medicine, and infectious disease markets. The company works across research, clinical development, manufacturing, and commercialization, giving it an integrated role in bringing vaccines from development to market. Its business is centered on specialty immunization products designed for targeted patient groups and healthcare providers, with a focus on prevention rather than treatment. Valneva SE is headquartered in Saint-Herblain, France.
Website6 rue Alain Bombard
Saint-Herblain, 44800
France
The latest articles about VALN.
Summary of Oct 8's posts. Generated by AI.
Summary of Jun 21's posts. Generated by AI.
Summary of Aug 14's posts. Generated by AI.
Investors talking about VALN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.